An increased presence of IL-17A-positive cells and high levels of IL-17A are associated with lymphatic vessel density (LVD), the smoking status, an advanced cancer stage (III/IV), and the poor survival of NSCLC patients [15,16]. Here, IL17A is linked to non-small cell lung carcinoma.